Amid the concerns surrounding potential rare side effects of the AstraZeneca-Oxford Covid-19 vaccine, the pharmaceutical ...

Cambridge [United Kingdom], May 1 (ANI): In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, that experts coined a new medical term: vaccine-induced thrombosis with ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

With a new hearing scheduled for November 27, 2024, questions persist regarding the safety of the vaccine ... several vaccines including AstraZeneca, Moderna, Pfizer-BioNTtech, Johnson and Johnson ...

AstraZeneca has paused its planned £450 million investment in the UK for vaccine R&D as it continues discussions with the ...

A Covid conspiracy theorist has been sentenced to five years behind bars after encouraging violence against Professor Sir ...

Last week, AstraZeneca reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile. An AstraZeneca spokesperson had stated, "Our sympathy goes out to anyone ...

“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...

Patient safety is our highest priority." The statement added that AstraZeneca’s vaccine “has continuously been shown to have an acceptable safety profile and regulators around the world ...